Farcoderma

What Farcoderma does

Farcoderma S.p.A. is an Italian Contract Development and Manufacturing Organization (CDMO) founded in 2006 and headquartered in Torre Pallavicina (Bergamo), Italy. The company contract-manufactures medical devices, food supplements, and cosmetic/dermocosmetic products on behalf of third-party healthcare clients (B2B white-label and bespoke production) and offers a ready-to-market catalog spanning more than 14 therapeutic areas. Since 2025, Farcoderma has operated as a subsidiary of Healthea Group, a newly formed European network consolidating leading CDMOs under a single brand with factories predominantly in Italy serving the European healthcare market.

Farcoderma's manufacturing covers multiple dosage and packaging formats — capsules (vegetable and animal gelatin, sizes 00 to 3), tablets, stick packs, strips, single-dose vials, tubes, glass bottles (15 ml to 1,000 ml), and airless cosmetic containers — produced in ISO 8 clean rooms with controlled temperature, humidity, and high-tech microfiltration. The company's differentiating technologies include proprietary Activ-Vial™ (single-dose vial system with patented drying polymer for humidity control and desiccant sheath), 3phase® by Bormioli (three-phase solid/liquid separation delivering 600% improved active ingredient protection against humidity), and licensed APTAR platforms spanning APF (Advanced Preservative Free) pumps (APF Plus, VP6, APF SNAP-ON 20) and APTAR Airless systems (Eden, Albion, Skin Master, Serumony, Digital Caresse). Production scales from pilot (10–15 kg) to industrial (5,000 kg), with Stick Pack capacity reaching up to 50,000 units per day.

Farcoderma generates revenue through two streams: contract manufacturing services (from pilot to industrial scale, inclusive of stability studies, PIF and dossier preparation) and white-label ready-to-market product sales. Pricing is quote-based, defined by client specifications, production volumes, and complexity rather than published rate cards. Go-to-market combines direct B2B sales engagement with channel access via the Healthea Group distribution network. Regulatory positioning is anchored by an unusually broad certification stack — ISO 13485 (medical devices), ISO 22716 (cosmetics GMP), ISO 22000 (food safety), FDA registration, GMP 21 CFR 111 (dietary supplements), ISO 17025 (laboratory), Halal, and Organic Production certifications — enabling access to regulated healthcare customers across device, cosmetic, and nutraceutical categories.

Name

Farcoderma

Legal name

Farcoderma S.p.A.

Website

https://farcoderma.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Farcoderma S.p.A. is an Italian B2B CDMO founded in 2006, headquartered in Torre Pallavicina (BG). It contract-manufactures medical devices, food supplements, and cosmetics for healthcare clients across 14+ therapeutic areas using ISO 8 clean rooms, Activ-Vial™, 3phase®, and APTAR packaging technologies.

Ownership category

akta.pro rank

Product category

Contract Development and Manufacturing Organization (CDMO)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medical Equipment and Supplies Manufacturing (3391)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industry

Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)

Keywords

• Contract manufacturing services
• Medical device manufacturing
• Food supplement production
• Cosmetic manufacturing
• Pharmaceutical packaging

Headquarters

HQ city

Bergamo

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Manufacturing (CMO): Manufacturing products on behalf of clients (third-party/white-label production). From pilot productions (10-15 kg) to industrial productions (5000 kg). Services include stability studies, PIF (Product Information File), and dossier preparation.
2. White Label / Ready-to-Market Products: Vast catalog of ready-to-market products in white label, particularly medical devices in over 14 therapeutic areas.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Farcoderma S.p.A. is a Contract Development and Manufacturing Organization (CDMO) that designs, develops, and manufactures medical devices, food supplements, and cosmetic products on behalf of healthcare companies. The company offers end-to-end services from formulation and R&D to pilot and industrial-scale production (up to 5,000 kg), along with ready-to-market white-label products spanning more than 14 therapeutic areas and specialized single-dose packaging technologies.

Product overview

FARCODERMA S.p.A. is a Contract Development and Manufacturing Organization (CDMO) operating as part of the Healthea Group. The company offers a comprehensive portfolio of healthcare products across three main categories: Medical Devices, Food Supplements, and Cosmetics. Medical Devices include various packaging formats with specialized APTAR pump technologies (SofTips, APF Plus, VP6, APF SNAP-ON 20, Mark II Pharma Pump) and airless technology. Food Supplements are produced in multiple dosage forms (capsules, tablets, stick packs, strips, single-dose vials, glass bottles) including Halal and Kosher certified options. Cosmetics feature APTAR pump airless technology products (Eden, Albion, Skin Master, Serumony, Digital Caresse). The company also offers specialized packaging formats including Stick Pack sachets, Activ-Vial™ single-dose system, and 3phase® by Bormioli three-phase vials. Manufacturing capabilities range from pilot production (10-15 kg) to industrial scale (5000 kg) in ISO 8 clean rooms, with contract manufacturing services available.

Differentiator

Problem solved

Functional benefit

Brands

• Activ-Vial: Innovative single-dose system with controlled sealing technology and desiccant sheath for humidity control, preserving product integrity and maximizing shelf life. Volumes from 54 ml to 150 ml.
• 3phase - Bormioli
• Stick Pack
• Eden - APTAR
• Albion - APTAR
• Skin Master - APTAR
• Serumony - APTAR
• Digital Caresse - APTAR
• SofTips - APTAR
• APF Plus - APTAR
• VP6 - APTAR
• APF SNAP-ON 20 - APTAR
• Mark II Pharma Pump

Products and services

• Medical Devices

Quantifiable outcome

• 600% improvement in active ingredient protection against humidity with 3phase packaging
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Healthea GroupcoreStrategic or Co-development PartnerHealthea Group is a European CDMO network established in 2025 that brings together the best CDMOs under a single brand. The group provides one of the widest commercial offerings in healthcare on the European market, with factories mainly in Italy capable of producing almost all galenic forms and all healthcare product categories.

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Recipharm: Swedish-headquartered CDMO serving pharma and consumer-health clients with solid, semi-solid, and sterile manufacturing plus packaging — overlaps with Farcoderma's contract-manufacturing model for supplements and medical devices.
• Aenova Group: One of Europe's largest CDMOs, offering solid oral dosage forms, sterile liquids, and packaging for pharmaceuticals, nutraceuticals, and consumer health — directly comparable to Farcoderma across multiple product categories and contract-manufacturing services.
• BSP Pharmaceuticals: Italian CDMO with injectable and lyophilized manufacturing plus solid oral capabilities; geographic and product overlap with Farcoderma makes it a useful comparator for Italian healthcare manufacturing scale and pricing.
• Idifarma: Spanish CDMO specializing in solid oral dosage forms, niche pharmaceuticals, and nutraceutical contract manufacturing with GMP and FDA capabilities — closely mirrors Farcoderma's solid/oral supplement CDMO offering.
• Olon Group: Italian API and generic-drug CDMO with GMP manufacturing across multiple dosage forms; useful comparator for contract-manufacturing pricing and European regulatory positioning similar to Farcoderma.

Broad incumbents

• Catalent: Global CDMO providing softgel, oral solid, and sterile manufacturing plus clinical supply services; a much larger incumbent operating in overlapping CDMO categories, useful as an upper-bound benchmark on scale and certifications.
• CordenPharma: International full-service CDMO covering peptides, injectables, and small molecules plus solid oral forms — broader scope than Farcoderma but overlapping solid-oral and packaging contract work for pharma and nutraceutical clients.

Regional players

• Stevanato Group: Italian manufacturer of pharmaceutical glass primary packaging and drug-delivery systems; comparable regional scale and Italian manufacturing footprint, with overlapping customer base in pharma/medical-device packaging.
• Pierrel Group: Italian contract manufacturer and supplier of pharmaceutical and consumer-health products including medical devices and supplements; regional Italian peer with similar customer profile and regulatory exposure.

Others

• Bormioli Pharma: Italian primary packaging supplier for the pharma industry and existing partner to Farcoderma via the 3phase® system; relevant as a supplier-side peer that defines the technology envelope for packaging-driven CDMOs.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/farcoderma

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Farcoderma